Clinical significance of heterogeneity in multifocal hepatocellular carcinoma: A multi-omics study
More than half of patients with hepatocellular carcinoma (HCC) have multiple lesions in the liver at the time when they attend the hospital, and there are limited treatment methods with poor efficacy for multifocal HCC in clinical practice. The high degree of tumor heterogeneity in multifocal HCC is...
Main Author: | KUANG Ming |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2020-10-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=11090 |
Similar Items
-
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
by: Markus W. Löffler, et al.
Published: (2019-04-01) -
Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
by: Dawei Cui, et al.
Published: (2021-09-01) -
Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma
by: Yu-jia Zhao, et al.
Published: (2021-01-01) -
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
by: Christos Dimitrakopoulos, et al.
Published: (2021-08-01) -
Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
by: Wenli Li, et al.
Published: (2019-10-01)